Advancing the development of diagnostic tests and biomarkers for tuberculosis

International Journal of Tuberculosis and Lung Disease

Volumn 15, Issue 7, 2011, Pages 985-987

  Yasinskaya, Yuliya ^a   Plikaytis, B ^b   Sizemore, C ^c   Sacks, L ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Biomarkers; TB; Tuberculosis

Indexed keywords

BIOLOGICAL MARKER; LIPOARABINOMANNAN;

ANTIBIOTIC SENSITIVITY; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; HUMAN; INTERFERON GAMMA RELEASE ASSAY; MYCOBACTERIUM TUBERCULOSIS; NUCLEIC ACID AMPLIFICATION; PRIORITY JOURNAL; SPUTUM CULTURE; SPUTUM CYTODIAGNOSIS; THORAX RADIOGRAPHY; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; BIOLOGICAL MARKERS; COOPERATIVE BEHAVIOR; DIAGNOSTIC TESTS, ROUTINE; DRUG RESISTANCE, BACTERIAL; HUMANS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 79958709871     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.10.0712     Document Type: Article

References (4)

1. Centers for Disease Control and Prevention. A strategic plan for the elimination of tuberculosis in the United States. MMWR 1989; 38: 269-272.
2. Institute of Medicine. Ending neglect: the elimination of tuberculosis in the United States. Washington DC, USA: Committee on the Elimination of Tuberculosis in the United States, Division of Health Promotion and Disease Prevention, Institute of Medicine, 2000.
3. Federal Tuberculosis Task Force. Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force. MMWR Recomm Rep 2009; 58 (RR-3): 1-43.
4. World Health Organization. Global tuberculosis control 2009: epidemiology, strategy, financing. WHO/HTM/TB/2009.411. Geneva, Switzerland: WHO, 2009.